To determine the clinical significance of EDIL3 expression in PDAC, the Chi-square test was used to assess the relationships between EDIL3 protein expression and corresponding patients’ clinicopathologic parameters including age, gender, tumor location, TNM stage, tumor size, T classification, lymph node metastasis, distant metastasis, vascular invasion and histological differentiation in TMA2. The gene discussed is EDIL3; the disease is neoplasm.